Aromatase inhibitor cuts risk of recurrence of breast cancer
AUTOR(ES)
White, Caroline
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=381155Documentos Relacionados
- Referral, Receipt, and Completion of Chemotherapy in Patients With Early-Stage Breast Cancer Older Than 65 Years and at High Risk of Breast Cancer Recurrence
- Increased risk of colorectal cancer following breast cancer.
- Overestimation of hereditary breast cancer risk.
- Is There Any Cardiovascular Concern Regarding the Use of Aromatase Inhibitors in Breast Cancer?
- CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors